BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38022450)

  • 1. Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients.
    Thevarkalam M; Kannoth S; Nambiar V; Gopinath S; Mathai A; Anandakuttan A; Krishnan S; Bhaskaran R
    Ann Indian Acad Neurol; 2023; 26(5):663-671. PubMed ID: 38022450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?
    Lacruz Ballester L; Fernandez-Fournier M; Puertas Muñoz I; Rodriguez Fraga O; Lastras Fernandez-Escandon C; Rodriguez de Rivera Garrido FJ; Alba Suarez EM; Tallon Barranco A
    Neurol Sci; 2022 Jan; 43(1):633-641. PubMed ID: 33914193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
    Madlener M; Strippel C; Thaler FS; Doppler K; Wandinger KP; Lewerenz J; Ringelstein M; Roessling R; Menge T; Wickel J; Kellingshaus C; Mues S; Kraft A; Linsa A; Tauber SC; Berg FT; Gerner ST; Paliantonis A; Finke A; Priller J; Schirotzek I; Süße M; Sühs KW; Urbanek C; Senel M; Sommer C; Kuempfel T; Pruess H; Fink GR; Leypoldt F; Melzer N; Malter MP;
    J Neurol Sci; 2023 Feb; 445():120540. PubMed ID: 36608627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of stiff-person syndrome with autoimmune endocrine diseases.
    Lee YY; Chen IW; Chen ST; Wang CC
    World J Clin Cases; 2019 Oct; 7(19):2942-2952. PubMed ID: 31624742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Syndromes Associated with Anti-GAD Antibodies.
    Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological disorders associated with glutamic acid decarboxylase 65 antibodies: Clinical spectrum and prognosis of a cohort from China.
    Bai L; Ren H; Liang M; Lu Q; Lin N; Liu M; Fan S; Cui R; Guan H
    Front Neurol; 2022; 13():990553. PubMed ID: 36277926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.
    Sharma CM; Pandey RK; Kumawat BL; Khandelwal D; Gandhi P
    Ann Indian Acad Neurol; 2016; 19(1):146-9. PubMed ID: 27011652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of glutamic acid decarboxylase antibodies in a Taiwanese population.
    Kuo YC; Lin CH
    Eur J Neurol; 2019 Nov; 26(11):1384-1390. PubMed ID: 31132202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy.
    Hou JY; Liu HU; Kuo CY; Liu YH; Lin JJ; Hsieh MY; Hung PC; Cheng YT; Su IC; Wang HS; Chou IJ; Lin KL
    Front Neurosci; 2022; 16():1081580. PubMed ID: 36817097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?
    Wang D; Huang K; Lin Z; Zhang Y; Liu G; Wu Y; Wang S
    Neurol Sci; 2020 Dec; 41(12):3691-3696. PubMed ID: 32514855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.
    Mäkelä KM; Hietaharju A; Brander A; Peltola J
    Front Neurol; 2018; 9():579. PubMed ID: 30057567
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-glutamic acid decarboxylase antibody (GAD) syndromes may have more aggressive disease course in African Americans and early onset of presentation compare to Caucasians group.
    Sriwastava S; Srinivas M; Kanna A; Yarraguntla K; Jowkar A; George E
    eNeurologicalSci; 2019 Dec; 17():100208. PubMed ID: 31646204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
    Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
    J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
    Sunwoo JS; Chu K; Byun JI; Moon J; Lim JA; Kim TJ; Lee ST; Jung KH; Park KI; Jeon D; Jung KY; Kim M; Lee SK
    J Neuroimmunol; 2016 Jan; 290():15-21. PubMed ID: 26711563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glutamic acid decarboxylase antibody screening in first-episode psychosis.
    Warren N; Freier K; Siskind D; O'Gorman C; Blum S; Gillis D; Scott JG
    Aust N Z J Psychiatry; 2023 Apr; 57(4):603-612. PubMed ID: 35362325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.